Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Variants at the Centromere02:30

Histone Variants at the Centromere

5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

3
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
3
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Nature medicine·2026
Same author

Multi-ancestry, trans-generational GWAS meta-analysis of gestational diabetes and glycaemic traits during pregnancy reveals limited evidence of pregnancy-specific genetic effects.

Nature communications·2026
Same author

Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.

Lancet (London, England)·2026
Same author

The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort study.

The Lancet. Global health·2025
Same author

Validation of the standard assessment of global everyday activities (SAGEA) scale for dementia diagnosis.

Age and ageing·2025
Same author

Trajectory of Early Life Adiposity Among South Asian Children.

JAMA network open·2025
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
Same journal

Estimated Pulse Wave Velocity Predicts Outcomes After Acute Ischemic Stroke: A Multinational Cohort Analysis.

American journal of hypertension·2026
Same journal

Chronic infection and metabolic stress: a converging axis driving hypertension and MASLD outcomes.

American journal of hypertension·2026
Same journal

Adipose Tissue Depots and Blood Pressure Regulation: Mechanisms, Biomarkers, and Targets Beyond Obesity.

American journal of hypertension·2026
Same journal

Methodological considerations for refining the prognostic utility of the HALP score in populations with hypertension.

American journal of hypertension·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K

Polypill Variants (Quarter Pill Trials).

Koon Teo1, Salim Yusuf1

  • 1PHRI Hamilton Health Sciences- McMaster University, Hamilton, Ontario, Canada.

American Journal of Hypertension
|March 20, 2018
PubMed
Summary
This summary is machine-generated.

The cardiovascular polypill, a single pill with multiple drugs, offers convenient prevention for cardiovascular disease (CVD). While showing promise in reducing risk factors and improving adherence, challenges remain for widespread adoption.

More Related Videos

Using an Ingestible Telemetric Temperature Pill to Assess Gastrointestinal Temperature During Exercise
08:22

Using an Ingestible Telemetric Temperature Pill to Assess Gastrointestinal Temperature During Exercise

Published on: October 7, 2015

11.1K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.1K

Related Experiment Videos

Last Updated: Feb 13, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Using an Ingestible Telemetric Temperature Pill to Assess Gastrointestinal Temperature During Exercise
08:22

Using an Ingestible Telemetric Temperature Pill to Assess Gastrointestinal Temperature During Exercise

Published on: October 7, 2015

11.1K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.1K

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Public Health

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • Current treatment strategies often involve multiple medications, leading to adherence challenges.
  • Fixed-dose combination pills, or polypills, offer a simplified therapeutic approach.

Purpose of the Study:

  • To review the proposed benefits and challenges of cardiovascular polypills.
  • To evaluate the efficacy of polypills in primary and secondary CVD prevention.
  • To identify barriers to the development and acceptance of polypill therapy.

Main Methods:

  • Review of existing literature on cardiovascular polypills.
  • Analysis of data on polypill effects on risk factors (hypertension, LDL levels).
  • Evaluation of adherence data compared to individual drug regimens.

Main Results:

  • Polypills combine multiple CVD-preventive drugs into a single tablet.
  • Effects on individual risk factors are comparable to separate medications.
  • Polypill use has demonstrated enhanced patient adherence.
  • Estimated risk reduction for CVD events ranges from 75% to 80%.

Conclusions:

  • Cardiovascular polypills present a promising strategy for CVD prevention, potentially improving adherence and reducing risk.
  • Significant regulatory, intellectual property, and perception-related barriers must be addressed for successful implementation.
  • Further large-scale, long-term randomized controlled trials are crucial to confirm predicted CVD outcome benefits.